Full Year 2010 Financial Detail Auxilium reported a net loss of $(51.2) million, or $(1.08) per share, for the full year 2010, compared to a net loss of $(53.5) million, or $(1.22) per share, for the full year 2009. Net loss for 2010 includes total stock-based compensation expense of $18.0 million, compared to $17.9 million for the full year 2009.
Gross margin on net revenues was 76% for the full year 2010, compared to 77 % for the full year 2009.
Research and development costs for the full year 2010 were $48.0 million compared with $51.4 million for the full year 2009.
Selling, general and administrative expenses totaled $164.7 million for the year ended December 31, 2010, compared with $129.2 million for the year-ago period.
Conference CallAuxilium will hold a conference call today, February 10, 2011 at 10:00 a.m. ET, to discuss fourth quarter and full year 2010 results, as well as the financial and operational guidance it has provided for 2011. The presentation slides to be used during the call are now available on the "For Investors" section of the Company's web site under the "Presentations" tab. A question and answer session will follow the presentation. The conference call and the presentation slides will be simultaneously web cast on the "For Investors" section of the Company's web site under the "Events" tab. The conference call will be archived for future review until May 10, 2011.Conference call details:Date:
Thursday, February 10, 2011Time:
10:00 a.m. ETDial-in (U.S.):
AUXILIUMTo access an audio replay of the call:Access number (U.S.):
888-286-8010Access number (International):
617-801-6888Replay Passcode #:
49964872About AuxiliumAuxilium Pharmaceuticals, Inc. is a
|SOURCE Auxilium Pharmaceuticals, Inc.|
Copyright©2010 PR Newswire.
All rights reserved